The Microdose GLP-1 Protocol at $129 per month flat provides a gentler entry point if you want to test tolerance before committing to standard-dose therapy
doi:10.1016/S0002-9440(10)61183-2
What You Need to Know Key Takeaways Taking semaglutide can increase your risk of thyroid C-cell tumors, pancreatitis, low blood sugar, acute kidney injury, diabetic retinopathy, and increased heart rate, and can cause suicidal thoughts and behaviors
17% estimated that they had not be supported enough for their diabetes after surgery
Rare: pancreatitis (we screen for risk factors), gallbladder issues during rapid weight loss, vision changes in diabetics
For people with type 2 diabetes, the SURPASS trial series demonstrated exceptional glycemic control alongside weight loss, which is why the compound received its first approval for diabetes before the obesity indication followed